|
This e-newsletter is sponsored by
|
|
Contact Us | |
American Society of
Bariatric Physicians
2821 S. Parker Road, Ste. 625
Aurora, CO 80014
office 303.770.2526 | asbp.org
Staff
Laurie Traetow, CAE
Executive Director
laurie@asbp.org
Colin Bennett
Director of Events &
Corporate Sponsorships
colin@asbp.org
Carly Crosby
Administrative Intern
carly@asbp.org
Heidi Gordon
Director of Marketing &
Communications
heidi@asbp.org
|
|
|
|
Obesity Medicine e-Weekly |
|
Advocacy
February issue of Capitol Resource now available
 This month's issue of the Society's monthly advocacy newsletter, Capitol Resource, is now available for download. Topics include:
- Obesity community responds to proposed regulations on multi-state plans and employer wellness programs
- Obesity community submits candidates for Patient-centered Outcomes Research Institute advisory panels |
|
News
ASBP Ex Officio Trustee and Health  Director to present research at European Congress on Obesity
The Society is pleased to announce that Ex Officio Trustee Ed J. Hendricks, M.D., and Health Director Stacy L. Schmidt, Ph.D., each have been accepted to present their research projects at the 2013 European Congress on Obesity.Dr. Hendricks will give an oral presentation for his abstract, Long-term Phentermine Pharmacotherapy: An Investigation for Amphetamine-like Phentermine Addiction, Cravings or Withdrawal. Dr. Hendricks will also present a poster on his abstract, Long-term Phentermine Pharmacotherapy: An Investigation for Amphetamine-like Abuse Potential. Dr. Schmidt will give an oral presentation on her abstract, Adrenergic Control of Lipolysis in Women compared to Men, and she will also present with ASBP President David A. Bryman, D.O., a poster based on changes in prescribing practices, taken from the Society's 2008 and 2012 Prescribing Practices Survey. The 20th European Congress on Obesity is May 12-15, 2013, in Liverpool, United Kingdom. Click here to learn more. |
Obesity Updates: Click titles to view articles
A review of seven myths about obesity, along with refuting evidence, was published in the New England Journal of Medicine last week. The seven myths include: 1) small sustained changes in energy intake or expenditure will produce large, long-term weight changes; 2) setting realistic goals in obesity treatment is important because otherwise patients will become frustrated and lose less weight; 3) large, rapid weight loss is associated with poorer long-term weight outcomes than is slow, gradual weight loss; 4) assessing the stage of change or diet readiness is important in helping patients who seek weight-loss treatment; 5) physical education classes in their current format play an important role in preventing or reducing childhood obesity; 6) breastfeeding is protective against obesity; and 7) a bout of sexual activity burns 100 to 300 kcals for each person involved. The authors claim that these seven myths are only a sampling of the numerous unsupported beliefs held by many people, and obesity scientists must continue to be open and honest with the public about the current state of knowledge on obesity.
The adipose organ
Adipose tissue is generally thought to consist of connective tissues without a specific anatomy. However, accumulating data support the idea that adipose tissue is organized to form a large organ with discrete anatomy, specific vascular and nerve supplies, complex cytology and high physiological plasticity. The organ is made up of several depots located in two compartments of the body: some are below the skin (subcutaneous depots) and some are in the trunk (visceral depots). Adipose tissue contributes to many of an organism's crucial survival needs: thermogenesis, lactation, immune responses and fuel for metabolism. In this article, the author provides a brief overview of the adipose organ, including brown adipose tissue, touching on cytology, physiological function and dynamics during health and disease.
Skeletal muscle is the primary tissue contributing to whole-body energy expenditure and is the main site for insulin-stimulated glucose disposal, which makes it a major factor in the pathogenesis of type 2 diabetes. The insulin-sensitizing effects of exercise are well known, and the activation of adenosine monophosphate-activated protein kinase (AMPK) in skeletal muscle by exercise may be the primary mechanism mediating this metabolic adaptation. Metformin, which many of your patients may be taking, activates AMPK, which promotes glucose uptake and fatty acid oxidation in skeletal muscle. Given that disturbances in these pathways contribute to insulin resistance in people with obesity, it is critical to understand the underlying mechanisms eliciting these effects, in order to develop new strategies (exercise and pharmacological) that will combat the growing problem of insulin resistance and type 2 diabetes. The importance of AMPK in regulating fatty acid metabolism and mitochondrial biogenesis has been highlighted in this review. Of note, the February issue of Molecular and Cellular Endocrinology highlights the many roles of AMPK in metabolic health and disease. For the entire table of contents, click here. |
|
Education
 Preliminary program now available with details about topics and speakers during Spring Obesity Conference
Save the date for the ASBP 2013 Spring Obesity Conference in San Diego on April 24-28 at the Manchester Grand Hyatt. Further details are now available by downloading a PDF of the preliminary program. In addition, online registration is available, or you may download and complete a PDF registration form for return via fax or USPS mail. Hotel reservations can be made online and start at $199+taxes (single/double).
 Upcoming Obesity Basic Medical Treatment Courses: North Carolina (Feb. 23) and New York (March 2)
The Obesity Medicine Association, a division of the Society, recently announced a partial list of 2013 dates and locations for the popular Obesity Basic Medical Treatment Course. Attendees earn 7 hours of continuing medical education, plus ASBP offers a $30 discount on the second and subsequent registrations received from the same office. The registration fee is $199, if received by the Wednesday prior to the course date. The course provides basic clinical information and tools to effectively treat obese patients and their related conditions. Learn more by downloading a PDF brochure. Click here to download a registration form and read details about the course. Online registration is available for these dates and locations:
- Feb. 23: Raleigh-Durham, N.C.
- March 2: Buffalo, N.Y.
- March 9: Oklahoma City
- March 16: Richmond, Va.
- March 23: Louisville, Ky.
|
|
|
|
|
